Gene · 7398
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shake and bake: a robust and cost-effective proteomic sample preparation workflow for plasma and cerebrospinal fluid. | Clin Proteomics | 2026 | 41692724 | PubTator, text mining | PubMed |
| NeuroD1-USP1-MYCN axis drives tumor progression in neuroblastoma. | J Transl Med | 2026 | 41673639 | PubTator, text mining | PubMed |
| Adipose-derived stem cell exosomes mitigate ferroptosis and enhance osteogenesis via miR-215-5p-mediated ubiquitin-specific protease 1 suppression. | Endocr J | 2026 | 41656108 | PubTator, text mining | PubMed |
| Uterine biophysical profile after intrauterine instillation of autologous blood cell derivative (ABCD) for thin endometrium in frozen embryo transfer cycles. | Arch Gynecol Obstet | 2026 | 41652209 | PubTator, text mining | PubMed |
| CRISPR/Cas9-based genome-wide screen reveals a synergistic effect of Irinotecan and USP1 inhibitor in colorectal cancer. | Eur J Pharmacol | 2026 | 41577322 | PubTator, text mining | PubMed |
| Targeted recruitment of USP15 enhances CTLA4 surface levels and restricts its degradation. | Life Sci Alliance | 2026 | 41571434 | PubTator, text mining | PubMed |
| Otubain deubiquitinases: Multi-layered regulators of cell fate, development, and stress responses across kingdoms. | iScience | 2026 | 41550777 | PubTator, text mining | PubMed |
| Chlorinated bis-4-hydroxycoumarins suppress flavivirus replication by inhibiting dengue virus type 2 translation and replication. | Sci Rep | 2026 | 41545435 | PubTator, text mining | PubMed |
| Biochemical and Comparative Proteomic Analyses Delineate the Anti-Ovarian Carcinogenic Roles of Modified Calycosin. | Food Sci Nutr | 2026 | 41541703 | PubTator, text mining | PubMed |
| Human cytomegalovirus regulates host DNA repair machinery for viral genome integrity. | Nucleic Acids Res | 2026 | 41533576 | PubTator, text mining | PubMed |
| RPA exhaustion activates SLFN11 to eliminate cells with heightened replication stress. | Nat Cell Biol | 2026 | 41514018 | PubTator, text mining | PubMed |
| Unanchored K63-linked polyubiquitin chains: a novel second messenger involved in G protein-coupled receptors early signaling events. | Cell Commun Signal | 2026 | 41507896 | PubTator, text mining | PubMed |
| Acute physiological responses during repeated sprint training with maximum end-expiratory breath-holds. | Eur J Appl Physiol | 2026 | 41182376 | PubTator, text mining | PubMed |
| Drugging the DNA damage response in the clinic: going beyond PARP. | Expert Rev Anticancer Ther | 2026 | 41086259 | PubTator, text mining | PubMed |
| NRF1 Transcriptionally Regulates USP1-Mediated Deubiquitination of AURKA to Facilitate Osteosarcoma Progression. | Mol Biotechnol | 2026 | 39915374 | PubTator, text mining | PubMed |
| Dual roles of USP1 in HELLS deubiquitination and SUMOylation drive EMT and FOLFOX-based chemoresistance. | Oncogenesis | 2025 | 41430042 | PubTator, text mining | PubMed |
| Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapy. | Nucleic Acids Res | 2025 | 41359388 | PubTator, text mining | PubMed |
| Discovery and Optimization of Novel Tricyclic Ubiquitin-Specific Protease 1 Inhibitors for the Treatment of BRCA-Mutated Breast Cancer. | J Med Chem | 2025 | 41347736 | PubTator, text mining | PubMed |
| KSQ-4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1-Mediated Multidrug Resistant Cancers. | MedComm (2020) | 2025 | 41328326 | PubTator, text mining | PubMed |
| Piperine Targets the FANCL/UBE2T Complex to Inhibit the FA Pathway and Sensitize Bladder Cancer to Cisplatin. | Dose Response | 2025 | 41306722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7398/papers?page=3